| Rosemary Seplowe, | |
|
3400 Bainbridge Ave, Montefiore Medical Center Map 3rd Floor, Bronx, NY 10467-2404 | |
| (718) 920-2333 | |
| (718) 920-8112 |
| Full Name | Rosemary Seplowe |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 33 Years |
| Location | 3400 Bainbridge Ave, Bronx, New York |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699940700 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 001324 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Shore - Lij Medical Pc | 3375701568 | 5099 |
| Montefiore Medical Center | 3779496021 | 2003 |
News Archive
The U.S. Food and Drug Administration approval of ibrutinib (Imbruvica) to treat patients with Waldenstrom's macroglobulinemia(WM) is a significant advance for patients with this rare blood cancer.
ULURU Inc., a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products, today announced the signing of a definitive agreement to sell an aggregate of 4,079,539 shares of its common stock at a price per share of $0.38 to a group of European investors, which is expected to result in gross proceeds of $1,550,225.
Textbook descriptions of brain cells make neurons look simple: a long spine-like central axon with branching dendrites.
A consequence of global warming is a greater frequency and intensity of extreme heat events. This extreme heat is associated with a greater risk of adverse cardiovascular incidents, especially for adults with pre-existing cardiovascular diseases.
Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics™, today announced that its collaboration and license agreement with AstraZeneca for the global development and commercialization of TC-5214 for major depressive disorder (MDD) has become effective as a result of early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.
› Verified 6 days ago
| Provider Name | Montefiore Medical Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1063525152 PECOS PAC ID: 3779496021 Enrollment ID: O20031113000235 |
News Archive
The U.S. Food and Drug Administration approval of ibrutinib (Imbruvica) to treat patients with Waldenstrom's macroglobulinemia(WM) is a significant advance for patients with this rare blood cancer.
ULURU Inc., a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products, today announced the signing of a definitive agreement to sell an aggregate of 4,079,539 shares of its common stock at a price per share of $0.38 to a group of European investors, which is expected to result in gross proceeds of $1,550,225.
Textbook descriptions of brain cells make neurons look simple: a long spine-like central axon with branching dendrites.
A consequence of global warming is a greater frequency and intensity of extreme heat events. This extreme heat is associated with a greater risk of adverse cardiovascular incidents, especially for adults with pre-existing cardiovascular diseases.
Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics™, today announced that its collaboration and license agreement with AstraZeneca for the global development and commercialization of TC-5214 for major depressive disorder (MDD) has become effective as a result of early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.
› Verified 6 days ago
| Provider Name | North Shore - Lij Medical Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1053688572 PECOS PAC ID: 3375701568 Enrollment ID: O20120220000262 |
News Archive
The U.S. Food and Drug Administration approval of ibrutinib (Imbruvica) to treat patients with Waldenstrom's macroglobulinemia(WM) is a significant advance for patients with this rare blood cancer.
ULURU Inc., a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products, today announced the signing of a definitive agreement to sell an aggregate of 4,079,539 shares of its common stock at a price per share of $0.38 to a group of European investors, which is expected to result in gross proceeds of $1,550,225.
Textbook descriptions of brain cells make neurons look simple: a long spine-like central axon with branching dendrites.
A consequence of global warming is a greater frequency and intensity of extreme heat events. This extreme heat is associated with a greater risk of adverse cardiovascular incidents, especially for adults with pre-existing cardiovascular diseases.
Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics™, today announced that its collaboration and license agreement with AstraZeneca for the global development and commercialization of TC-5214 for major depressive disorder (MDD) has become effective as a result of early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rosemary Seplowe, 3400 Bainbridge Ave, Montefiore Medical Center Map 3rd Floor, Bronx, NY 10467-2404 Ph: (718) 920-2333 | Rosemary Seplowe, 3400 Bainbridge Ave, Montefiore Medical Center Map 3rd Floor, Bronx, NY 10467-2404 Ph: (718) 920-2333 |
News Archive
The U.S. Food and Drug Administration approval of ibrutinib (Imbruvica) to treat patients with Waldenstrom's macroglobulinemia(WM) is a significant advance for patients with this rare blood cancer.
ULURU Inc., a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products, today announced the signing of a definitive agreement to sell an aggregate of 4,079,539 shares of its common stock at a price per share of $0.38 to a group of European investors, which is expected to result in gross proceeds of $1,550,225.
Textbook descriptions of brain cells make neurons look simple: a long spine-like central axon with branching dendrites.
A consequence of global warming is a greater frequency and intensity of extreme heat events. This extreme heat is associated with a greater risk of adverse cardiovascular incidents, especially for adults with pre-existing cardiovascular diseases.
Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics™, today announced that its collaboration and license agreement with AstraZeneca for the global development and commercialization of TC-5214 for major depressive disorder (MDD) has become effective as a result of early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.
› Verified 6 days ago
Alla Avdashchenko, MA, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1400 Pelham Pkwy S, Building 1, Room 5n1, Bronx, NY 10461 Phone: 718-918-6275 | |
Tricia Anne Raymond, Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1200 Waters Pl Ste 110, Bronx, NY 10461 Phone: 718-863-4366 | |
Mrs. Evmorfia Tzanis, MA, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 130 W Kingsbridge Rd, Bronx, NY 10468 Phone: 718-584-9000 | |
Dr. Brenda Lilia Guerrero, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 1650 Grand Concourse, Bronx, NY 10457 Phone: 718-518-5864 | |
Dr. Carmen Santiago, AU.D Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1650 Grand Concourse, Bronx, NY 10457 Phone: 718-518-5659 | |
Pelham Audiology Assoc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1934 Williamsbridge Rd, Bronx, NY 10461 Phone: 718-822-4100 | |
Nikol Leitner, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3400 Bainbridge Ave. Map 3rd Floor, Montefiore Medical Center, Dept Of Otorhinolaryngology, Bronx, NY 10467 Phone: 718-920-4250 Fax: 718-920-8112 |